PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers identify new brain receptor for fantasy

2012-07-03
(Press-News.org) Researchers are closer to understanding the biology behind GHB, a transmitter substance in the brain, best known in its synthetic form as the illegal drug fantasy. These findings have just been published in the scientific journal PNAS.

In the 1960s, gamma-hydroxybutyric acid (GHB) was first discovered as a naturally occurring substance in the brain. Since then it has been manufactured as a drug with a clinical application and has also developed a reputation as the illegal drug fantasy and as a date rape drug. Its physiological function is still unknown. Researchers identify new brain receptor for fantasy

Now a team of researchers at the Department of Drug Design and Pharmacology at the University of Copenhagen has shown for the first time exactly where the transmitter substance binds in the brain under physiologically relevant conditions. The results have recently been published in the scientific journal PNAS – Proceedings of the National Academy of Sciences USA:

"We have discovered that GHB binds to a special protein in the brain – more specifically a GABAA-receptor. The binding is strong even at very low dosage. This suggests that we have found the natural receptor, which opens new and exciting research opportunities, in that we have identified an important unknown that can provide the basis for a full explanation of the biological significance of the transmitter," says Laura Friis Eghorn, PhD student.

Fantasy is also used as a so-called date rape drug, because in moderate amounts it has sedative, sexually stimulating and soporific effects. The compound is also abused for its euphoric effect, but in combination with alcohol, for example, it is a deadly cocktail that can lead to a state of deep unconsciousness or coma.

"GHB is registered for use as a drug to treat alcoholism and certain types of sleep disorders, but the risk of abuse presents difficulties. In the long-term, understanding how GHB works will enable us to develop new and better pharmaceuticals with a targeted effect in the brain, without the dangerous side-effects of fantasy," explains Laura Friis Eghorn, Department of Drug Design and Pharmacology.

Fantasy is an extremely toxic euphoriant, because the difference between a normal intoxicating dose and a fatal dose is so small. A better understanding of the biological mechanisms behind GHB-binding in the brain will benefit research into a life-saving antidote for this drug. Today there is no known antidote.

Statistics from Denmark in 2010 show that 8-10 percent of young people who frequent night clubs have had experience with Fantasy. However, since the drug is often also used in private for its sedative effect, it is difficult to estimate the extent of abuse.

The new research findings are the result of a collaboration between researchers at the University of Sydney in Australia and medicinal chemists at the Faculty of Health and Medical Sciences:

"Our chemist colleagues designed and produced special ligands – that are mimics of GHB in several variations. This enabled us to go on a targeted fishing expedition in the brain. We have slowly found our way to the receptor, which we have also been able to test pharmacologically. In itself, it is not unusual to find new receptors in the brain for known compounds. However, when we find a natural match rooted in the brain's transmitter system, the biological implications are extremely interesting," explains Petrine Wellendorph, associate professor and head of the responsible research group that produced the pioneering results.

INFORMATION:

Contact information:

PhD student Laura Friis Eghorn
Department of Drug Design and Pharmacology
The Faculty of Health and Medical Sciences
Mobile: +45 23 96 84 97
Mail: lfe@farma.ku.dk

Associate Professor Petrine Wellendorph
Department of Drug Design and Pharmacology
The Faculty of Health and Medical Sciences
Mobile: +45 61 30 28 26
Mail: pw@farma.ku.dk

Communications Officer
Stine Rasmussen
Mobile: +45 20 92 27 30
Mail: sr@farma.ku.dk

END



ELSE PRESS RELEASES FROM THIS DATE:

Years before diagnosis, quality of life declines for Parkinson's disease patients

2012-07-03
Amsterdam, NL, July 2, 2012 – Growing evidence suggests that Parkinson's disease (PD) often starts with non-motor symptoms that precede diagnosis by several years. In the first study to examine patterns in the quality of life of Parkinson' disease patients prior to diagnosis, researchers have documented declines in physical and mental health, pain, and emotional health beginning several years before the onset of the disease and continuing thereafter. Their results are reported in the latest issue of Journal of Parkinson's Disease. "We observed a decline in physical function ...

Autism, schizophrenia and bipolar disorder may share common underlying factors, study suggests

2012-07-03
(Embargoed) CHAPEL HILL, NC – New research led by a medical geneticist at the University of North Carolina School of Medicine points to an increased risk of autism spectrum disorders (ASDs) among individuals whose parents or siblings have been diagnosed with schizophrenia or bipolar disorder. The findings were based on a case-control study using population registers in Sweden and Israel, and the degree to which these three disorders share a basis in causation "has important implications for clinicians, researchers and those affected by the disorders," according to a report ...

Innate immune system protein provides a new target in war against bacterial infections

2012-07-03
Research led by St. Jude Children's Research Hospital scientists has identified a possible new approach to defeating bacterial infections by targeting an innate immune system component in a bid to invigorate the immune response. In this study, researchers demonstrated that the primary function of one of the innate immune molecules is to suppress inflammation, which in turn dampens the immune response to infections and other threats. Investigators showed the protein works by inhibiting two pathways that control production of specialized molecules that fight infections. ...

Tevatron scientists announce their final results on the Higgs particle

2012-07-03
After more than 10 years of gathering and analyzing data produced by the U.S. Department of Energy's Tevatron collider, scientists from the CDF and DZero collaborations have found their strongest indication to date for the long-sought Higgs particle. Squeezing the last bit of information out of 500 trillion collisions produced by the Tevatron for each experiment since March 2001, the final analysis of the data does not settle the question of whether the Higgs particle exists, but gets closer to an answer. The Tevatron scientists unveiled their latest results on July 2, ...

Electronic medical record improves physician compliance of reviewing portal images, study suggests

2012-07-03
The use of an electronic medical record (EMR) for reviewing portal images dramatically improves compliance with timeliness and record keeping, according to a study in the July issue of the Journal of the American College of Radiology. Portal images are used to verify the positioning of patients during daily radiation treatments to improve the accuracy of the radiation field placement, to reduce exposure to normal tissue and to deliver accurate dose to tumor volumes. "The benefits of the implementation and utilization of an EMR have been well documented. Other studies ...

APA task force recommends treatment guidelines and position statements on transgender persons

2012-07-03
A report from the American Psychiatric Association (APA) Task Force on Treatment of Gender Identity Disorder (GID) recommends the development of clinical practice guidelines for psychiatrists caring for patients who are transgender. The report also encourages the development of position statements regarding the health care and civil rights of people who are gender variant or transitioning gender. The task force report is available online in Springer's journal Archives of Sexual Behavior¹. The task force was charged with reviewing the scientific literature regarding gender ...

'Self-distancing' can help people calm aggressive reactions, study finds

2012-07-03
COLUMBUS, Ohio - A new study reveals a simple strategy that people can use to minimize how angry and aggressive they get when they are provoked by others. When someone makes you angry, try to pretend you're viewing the scene at a distance - in other words, you are an observer rather than a participant in this stressful situation. Then, from that distanced perspective, try to understand your feelings. Researchers call this strategy "self-distancing." In one study, college students who believed a lab partner was berating them for not following directions responded less ...

Mosquitoes -- how we smell is why they bite, research shows

2012-07-03
Now that the summer season is in full swing, many of us will be hosting picnics and barbecues and socializing outside. Chances are, we'll also have some unwanted guests in the form of mosquitoes. Mosquitoes seem to have an uncanny ability to locate us and Zainulabeuddin Syed, a mosquito biologist with the University of Notre Dame's Eck Institute for Global Health, has gone a long way toward to determining how they do it. In short, it's because of the way we smell. Zain studies olfaction in mosquitoes and other insects and he points out that mosquitoes have an extraordinary ...

Imaging agents predict breast cancer response to endocrine therapy

2012-07-03
Reston, Va. (July 2, 2012) – Research published in the July issue of The Journal of Nuclear Medicine shows imaging progesterone receptor (PR) status also may be able to identify responders and nonresponders to endocrine therapy at an early stage. Estrogen receptor-α (ERα) status is an important factor in determining the most appropriate treatment for breast cancer patients, especially for those who are ERα+ and likely to respond well to hormone-based, or endocrine, therapies. Prominent professor and research chemist Michael J. Welch, PhD, who passed away ...

Child abuse and foster care admissions increase when parents use methamphetamines

2012-07-03
WACO, Texas (July 2, 2012) - Methamphetamine abuse leads to an increase in child abuse and neglect, which causes an increase in foster care admissions, according to a study from Baylor University. The study, published online in the journal Economic Inquiry, found that a 1 percent increase in meth use led to a 1.5 percent increase in foster care admissions. It is the first study to provide evidence for meth abuse's causal effect on foster home admissions. Follow this link to read the entire study: http://onlinelibrary.wiley.com/doi/10.1111/j.1465-7295.2012.00481.x/full "Our ...

LAST 30 PRESS RELEASES:

Father’s mental health can impact children for years

Scientists can tell healthy and cancerous cells apart by how they move

Male athletes need higher BMI to define overweight or obesity

How thoughts influence what the eyes see

Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect

Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation

Could opioid laws help curb domestic violence? New USF research says yes

NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow

Scientists identify agent of transformation in protein blobs that morph from liquid to solid

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Research identifies key enzyme target to fight deadly brain cancers

New study unveils volcanic history and clues to ancient life on Mars

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

Scientists probe the mystery of Titan’s missing deltas

Q&A: What makes an ‘accidental dictator’ in the workplace?

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

Study highlights gaps in firearm suicide prevention among women

People with medical debt five times more likely to not receive mental health care treatment

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

Rise in claim denial rates for cancer-related advanced genetic testing

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

Medical debt and forgone mental health care due to cost among adults

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

AERA announces winners of the 2025 Palmer O. Johnson Memorial Award

Mapping minds: The neural fingerprint of team flow dynamics

Patients support AI as radiologist backup in screening mammography

AACR: MD Anderson’s John Weinstein elected Fellow of the AACR Academy

Existing drug has potential for immune paralysis

[Press-News.org] Researchers identify new brain receptor for fantasy